NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma

NIH Image to ImageJ: 25 years of image analysis

Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638 · see citing works

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649 · see citing works

The Epidemiology of Osteosarcoma

Ottaviani, G., & Jaffe, N. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_1 · Cited by 1,793 · see citing works

Impact of mutant p53 functional properties on <i>TP53</i> mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007) · Human Mutation · doi:10.1002/humu.20495 · Cited by 1,598 · see citing works

Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome

Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308 · see citing works

When mutants gain new powers: News from the mutant p53 field

Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132 · see citing works

Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Kager, L., Zoubek, A., Pötschger, U., Kastner, U., Flege, S., Kempf-Bielack, B., Branscheid, D., Kotz, R., Salzer-Kuntschik, M., Winkelmann, W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.132 · Cited by 934 · see citing works

Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes

Molenaar, J. J., Köster, J., Zwijnenburg, D. A., Sluis, P. V., Valentijn, L. J., van der Ploeg, I., Hamdi, M., van Nes, J., Westerman, B. A., van Arkel, J., et al. (2012) · Nature · doi:10.1038/nature10910 · Cited by 869 · see citing works

Genetic determinants of cancer metastasis

Nguyen, D. X., & Massagué, J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2101 · Cited by 796 · see citing works

Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma

Chen, X., Bahrami, A., Pappo, A., Easton, J., Dalton, J., Hedlund, E., Ellison, D., Shurtleff, S., Wu, G., Wei, L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.003 · Cited by 752 · see citing works

Osteogenic sarcoma with clinically detectable metastasis at initial presentation.

Meyers, P. A., Heller, G., Healey, J. H., Huvos, A. G., Applewhite, A., Sun, M., & LaQuaglia, M. P. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.449 · Cited by 389 · see citing works

miRNA control of tumor cell invasion and metastasis

Baranwal, S., & Alahari, S. K. (2009) · International Journal of Cancer · doi:10.1002/ijc.25014 · Cited by 316 · see citing works

Molecular Pathogenesis of Osteosarcoma

Kansara, M., & Thomas, D. M. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0505 · Cited by 273 · see citing works

Dickkopf 3 Inhibits Invasion and Motility of Saos-2 Osteosarcoma Cells by Modulating the Wnt-β-Catenin Pathway

Hoang, B. H., Kubo, T., Healey, J. H., Yang, R., Nathan, S. S., Kolb, E. A., Mazza, B., Meyers, P. A., & Gorlick, R. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1952 · Cited by 261 · see citing works

Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis

Cheng, J. H., She, H., Han, Y., Wang, J., Xiong, S., Asahina, K., & Tsukamoto, H. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00263.2007 · Cited by 259 · see citing works

Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes

Lauvrak, S. U., Munthe, E., Kresse, S. H., Stratford, E. W., Namløs, H. M., Meza‐Zepeda, L. A., & Myklebost, O. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.549 · Cited by 248 · see citing works

An Orthotopic Model of Human Osteosarcoma Growth and Spontaneous Pulmonary Metastasis

Luu, H. H., Kang, Q., Park, J. K., Si, W., Luo, Q., Jiang, W., Yin, H. X., MONTAG, A. G., Simon, M. A., Peabody, T. D., et al. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-0365-9 · Cited by 233 · see citing works

Endogenous interferon-γ is required for efficient skeletal muscle regeneration

Cheng, M., Nguyen, M.-H., Fantuzzi, G., & Koh, T. J. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00568.2007 · Cited by 214 · see citing works

High metastatic potential in mice inheriting a targeted p53 missense mutation

Liu, G., McDonnell, T. J., Luna, R. M. D. O., Kapoor, M., Mims, B. H., El‐Naggar, A. K., & Lozano, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4174 · Cited by 198 · see citing works

Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues

Liu, F., Woitge, H. W., Braut, A., Kronenberg, M. S., Lichtler, A. C., Mina, M., & Kream, B. E. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041816fl · Cited by 195 · see citing works

20 years studying p53 functions in genetically engineered mice

Donehower, L. A., & Lozano, G. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2731 · Cited by 193 · see citing works

Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide

Bacci, G., Briccoli, A., Rocca, M., Ferrari, S., Donati, D. M., Longhi, A., Bertoni, F., Bacchini, P., Giacomini, S., Forni, C., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg286 · Cited by 187 · see citing works

Dickkopf-3/REIC functions as a suppressor gene of tumor growth

Hsieh, S., Hsieh, P.-S., Chiu, C., & Chen, W.-Y. (2004) · Oncogene · doi:10.1038/sj.onc.1208138 · Cited by 168 · see citing works

Cell autonomous regulation of multiple Dishevelled-dependent pathways by mammalian Nkd

Yan, D. M., Wallingford, J. B., Sun, T., Nelson, A. M., Sakanaka, C., Reinhard, C., Harland, R. M., Fantl, W. J., & Williams, L. T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071041898 · Cited by 167 · see citing works

naked cuticle targets dishevelled to antagonize Wnt signal transductionPreprint

Rousset, R., Mack, J. A., Wharton, K. A., Axelrod, J. D., Cadigan, K. M., Fish, M., Nusse, R., & Scott, M. P. (2001) · Genes & Development · doi:10.1101/gad.869201 · Cited by 160 · see citing works

Correlation between CpG methylation profiles and hormone receptor status in breast cancers

Feng, W., Shen, L., Wen, S., Rosen, D. G., Jelı́nek, J., Hu, X., Huan, S., Huang, M. L., Liu, J., Şahin, A. A., et al. (2007) · Breast Cancer Research · doi:10.1186/bcr1762 · Cited by 154 · see citing works

Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas

Götze, S., Wolter, M., Reifenberger, G., Müller, O., & Sievers, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24981 · Cited by 144 · see citing works

Wnt signaling and the regulation of bone mass

Baron, R., & Rawadi, G. (2007) · Current Osteoporosis Reports · doi:10.1007/s11914-007-0006-0 · Cited by 127 · see citing works

Biology of Osteogenic Sarcoma

Wang, L. L. (2005) · The Cancer Journal · doi:10.1097/00130404-200507000-00005 · Cited by 126 · see citing works

Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos‐2 cells

Guo, Y., Zi, X., Koontz, M. Z., Kim, A., Xie, J., Gorlick, R. G., Holcombe, R. F., & Hoang, B. H. (2007) · Journal of Orthopaedic Research® · doi:10.1002/jor.20356 · Cited by 116 · see citing works

Downregulation of several fibulin genes in prostate cancer

Wlazlinski, A., Engers, R., Hoffmann, M. J., Hader, C., Jung, V., Müller, M., & Schulz, W. A. (2007) · The Prostate · doi:10.1002/pros.20667 · Cited by 105 · see citing works

Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours

Veeck, J., Bektas, N., Hartmann, A., Kristiansen, G., Heindrichs, U., Knüchel, R., & Dahl, E. (2008) · Breast Cancer Research · doi:10.1186/bcr2151 · Cited by 96 · see citing works

Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma

Kanda, M., Nomoto, S., Okamura, Y., Hayashi, M., Hishida, M., Fujii, T., Nishikawa, Y., Sugimoto, H., Takeda, S., & Nakao, A. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20735 · Cited by 86 · see citing works

Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog

Johnson, A. J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.213 · Cited by 80 · see citing works

REIC/Dkk-3 induces cell death in human malignant glioma

Mizobuchi, Y., Matsuzaki, K., Kuwayama, K., Kitazato, K. T., Mure, H., Kageji, T., & Nagahiro, S. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-016 · Cited by 74 · see citing works

Myristoylated Naked2 escorts transforming growth factor α to the basolateral plasma membrane of polarized epithelial cells

Li, C., Franklin, J. L., Graves‐Deal, R., Jerome, W. G., Cao, Z., & Coffey, R. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401294101 · Cited by 73 · see citing works

CXCR4 antibody treatment suppresses metastatic spread to the lung of intratibial human osteosarcoma xenografts in mice

Brennecke, P., Arlt, M., Campanile, C., Husmann, K., Gvozdenovic, A., Apuzzo, T., Thelen, M., Born, W., & Fuchs, B. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9632-3 · Cited by 73 · see citing works

Adenovirus-mediated REIC/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model

Edamura, K., Nasu, Y., Takaishi, M., Kobayashi, T., Abarzúa, F., Sakaguchi, M., Kashiwakura, Y., Ebara, S., Saika, T., Watanabe, M., et al. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701071 · Cited by 64 · see citing works

Myristoylated Naked2 Antagonizes Wnt-β-Catenin Activity by Degrading Dishevelled-1 at the Plasma Membrane

Hu, T., Li, C., Cao, Z., Raay, T. J. V., Smith, J. G., Willert, K., Solnica‐Krezel, L., & Coffey, R. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.075945 · Cited by 59 · see citing works

A Mouse Model of Pulmonary Metastasis from Spontaneous Osteosarcoma Monitored In Vivo by Luciferase Imaging

Miretti, S., Roato, I., Taulli, R., Ponzetto, C., Cilli, M., Olivero, M., Renzo, M. F. D., Godio, L., Albini, A., Buracco, P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001828 · Cited by 58 · see citing works

Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells

Kimura, R., Ishikawa, C., Rokkaku, T., Janknecht, R., & Mori, N. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.04.008 · Cited by 56 · see citing works

Matrix Metalloproteinase 1 promotes tumor formation and lung metastasis in an intratibial injection osteosarcoma mouse model

Husmann, K., Arlt, M., Muff, R., Langsam, B., Bertz, J., Born, W., & Fuchs, B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.006 · Cited by 51 · see citing works

A systems biology approach reveals common metastatic pathways in osteosarcoma

Flores, R. J., Li, Y., Yu, A. K.-T., Shen, J. J., Rao, P. H., Lau, S. S., Vannucci, M., Lau, C. C., & Man, T. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-50 · Cited by 51 · see citing works

Naked2 Acts as a Cargo Recognition and Targeting Protein to Ensure Proper Delivery and Fusion of TGF-α–containing Exocytic Vesicles at the Lower Lateral Membrane of Polarized MDCK Cells

Li, C., Hao, M., Cao, Z., Ding, W., Graves‐Deal, R., Hu, J., Piston, D. W., & Coffey, R. J. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-02-0172 · Cited by 43 · see citing works

Genes Regulated in Metastatic Osteosarcoma: Evaluation by Microarray Analysis in Four Human and Two Mouse Cell Line Systems

Muff, R., Kumar, R. M. R., Botter, S. M., Born, W., & Fuchs, B. (2012) · Sarcoma · doi:10.1155/2012/937506 · Cited by 39 · see citing works

Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin‐like growth factor I

Hong, S., Briggs, J., Newman, R. J., Hoffman, K. E., Mendoza, A., LeRoith, D., Helman, L. J., Yakar, S., & Khanna, C. (2008) · International Journal of Cancer · doi:10.1002/ijc.24169 · Cited by 18 · see citing works

Generation and Characterization of p53 Mutant Mice

Dumble, M. L., Donehower, L. A., & Lu, X. (2003) · Humana Press eBooks · doi:10.1385/1-59259-408-5:29 · Cited by 12 · see citing works

Decoding myofibroblast origins in human kidney fibrosis

Kuppe, C., Ibrahim, M. M., Kranz, J., Zhang, X., Ziegler, S., Perales-Patón, J., Jansen, J., Reimer, K. C., Smith, J. R., Dobie, R., et al. (2021) · Nature · doi:10.1038/s41586-020-2941-1 · Cited by 769 · see citing works

Osteosarcoma

Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660 · see citing works

Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy

Cersosimo, F., Lonardi, S., Bernardini, G., Telfer, B., Mandelli, G. E., Santucci, A., Vermi, W., & Giurisato, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155207 · Cited by 280 · see citing works

Molecular genetics of osteosarcoma

Rickel, K., Fang, F., & Tao, J. (2016) · Bone · doi:10.1016/j.bone.2016.10.017 · Cited by 244 · see citing works

Osteosarcoma: Accelerating Progress Makes for a Hopeful Future

Saraf, A. J., Fenger, J. M., & Roberts, R. D. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00004 · Cited by 237 · see citing works

Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy

Angulo, P., Kaushik, G., Subramaniam, D., Dandawate, P. R., Neville, K. A., Chastain, K. M., & Anant, S. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0373-z · Cited by 186 · see citing works

cBAF complex components and MYC cooperate early in CD8+ T cell fate

Guo, A., Huang, H., Zhu, Z., Chen, J., Shi, H., Yuan, S., Sharma, P., Connelly, J. P., Liedmann, S., Dhungana, Y., et al. (2022) · Nature · doi:10.1038/s41586-022-04849-0 · Cited by 169 · see citing works

Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression

Nie, F., Yu, X., Huang, M., Wang, Y., Xie, M., Ma, H., Wang, Z., De, W., & Sun, M. (2016) · Oncotarget · doi:10.18632/oncotarget.9611 · Cited by 155 · see citing works

Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group

Roberts, R. D., Lizardo, M. M., Reed, D. R., Hingorani, P., Glover, J., Allen‐Rhoades, W., Fan, T., Khanna, C., Sweet‐Cordero, E. A., Cash, T., et al. (2019) · Cancer · doi:10.1002/cncr.32351 · Cited by 127 · see citing works

Molecular mechanisms underpinning sarcomas and implications for current and future therapy

Damerell, V., Pepper, M. S., & Prince, S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00647-8 · Cited by 114 · see citing works

Wnt Signaling in Osteosarcoma

Lin, C. H., Ji, T., Chen, C., & Hoang, B. H. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_2 · Cited by 114 · see citing works

Whole proteome analysis of human tankyrase knockout cells reveals targets of tankyrase-mediated degradation

Bhardwaj, A., Yang, Y., Ueberheide, B. M., & Smith, S. H. (2017) · Nature Communications · doi:10.1038/s41467-017-02363-w · Cited by 101 · see citing works

Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma

Nomura, M., Rainusso, N., Lee, Y.-C., Dawson, B., Coarfa, C., Han, R., Larson, J. L., Shuck, R., Kurenbekova, L., & Yustein, J. T. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz026 · Cited by 99 · see citing works

Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411)

Schafer, E. S., Rau, R. E., Berg, S. L., Liu, X., Minard, C. G., Bishop, A. J. R., Romero, J. C., Hicks, J. M., Nelson, M. D., Voss, S. D., et al. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.28073 · Cited by 89 · see citing works

SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT–receptor complex

Zhao, S.-J., Jiang, Y.-Q., Xu, N.-W., Li, Q., Zhang, Q., Wang, S.-Y., Li, J., Wang, Y.-H., Zhang, Y., Jiang, S., et al. (2017) · Oncogene · doi:10.1038/onc.2017.403 · Cited by 89 · see citing works

New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?

Danieau, G., Morice, S., Rédiní, F., Verrecchia, F., & Royer, B. B.-L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153751 · Cited by 85 · see citing works

IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis

Gross, A. C., Cam, H., Phelps, D. A., Saraf, A. J., Bid, H. K., Cam, M., London, C. A., Winget, S. A., Arnold, M. A., Brandolini, L., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99791 · Cited by 82 · see citing works

From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma

Dean, D. C., Shen, S., Hornicek, F. J., & Duan, Z. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9763-8 · Cited by 84 · see citing works

Cross‐species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma

Allen‐Rhoades, W. A., Kurenbekova, L., Satterfield, L., Parikh, N., Fuja, D. G., Shuck, R. L., Rainusso, N. C., Trucco, M. M., Barkauskas, D. A., Jo, E., et al. (2015) · Cancer Medicine · doi:10.1002/cam4.438 · Cited by 81 · see citing works

A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model

Goldstein, S. D., Trucco, M., Guzman, W. B., Hayashi, M., & Loeb, D. M. (2016) · Oncotarget · doi:10.18632/oncotarget.8522 · Cited by 78 · see citing works

A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas

Deel, M. D., Li, J., Crose, L. E. S., & Linardic, C. M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00190 · Cited by 71 · see citing works

Targeting the Wnt/β-catenin pathway in human osteosarcoma cells

Fang, F., VanCleave, A. M., Helmuth, R., de Oliveira, H. T., Rickel, K., Wollenzien, H., Sun, H., Zeng, E., Zhao, J., & Tao, J. (2018) · Oncotarget · doi:10.18632/oncotarget.26377 · Cited by 71 · see citing works

Long noncoding RNA HULC promotes colorectal carcinoma progression through epigenetically repressing NKD2 expression

Yang, X., Huang, C., Peng, C., Hou, J., & Liu, J.-Y. (2016) · Gene · doi:10.1016/j.gene.2016.08.002 · Cited by 69 · see citing works

Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance

Walia, M., Ho, P. M., Taylor, S., Ng, A. J., Gupte, A., Chalk, A. M., Zannettino, A. C. W., Martin, T. J., & Walkley, C. R. (2016) · eLife · doi:10.7554/elife.13446 · Cited by 55 · see citing works

Deciphering signaling networks in osteosarcoma pathobiology

Adamopoulos, C., Gargalionis, A. N., Basdra, E. K., & Papavassiliou, A. G. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216648806 · Cited by 51 · see citing works

Matrix‐Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis

Zandueta, C., Ormazabal, C., Perurena, N., Martínez-Canarias, S., Zalacaín, M., San-Julián, M., Grigoriadis, A. E., Valencia, K., Campos-Laborie, F. J., Rivas, J. D. L., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4740 · Cited by 51 · see citing works

Wnt Signaling in Osteosarcoma

Singla, A. K., Wang, J., Yang, R., Geller, D. S., Loeb, D. M., & Hoang, B. H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43085-6_8 · Cited by 50 · see citing works

Omega-3 Fatty Acids DHA and EPA Reduce Bortezomib Resistance in Multiple Myeloma Cells by Promoting Glutathione Degradation

Chen, J., Zaal, E. A., Berkers, C. R., Ruijtenbeek, R., Garssen, J., & Redegeld, F. A. (2021) · Cells · doi:10.3390/cells10092287 · Cited by 49 · see citing works

Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential

Techavichit, P., Gao, Y., Kurenbekova, L., Shuck, R. L., Donehower, L. A., & Yustein, J. T. (2016) · BMC Cancer · doi:10.1186/s12885-016-2909-6 · Cited by 48 · see citing works

Chrysophanol, a main anthraquinone from Rheum palmatum L. (rhubarb), protects against renal fibrosis by suppressing NKD2/NF-κB pathway

Gu, M., Zhou, Y., Liao, N., Wei, Q., Bai, Z., Bao, N., Zhu, Y., Zhang, H., Gao, L., & Cheng, X. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154381 · Cited by 47 · see citing works

Molecular pathogenesis and therapeutic strategies of human osteosarcoma

Denduluri, S. K., Wang, Z., Yan, Z., Wang, J., Wei, Q., Mohammed, M. K., Haydon, R. C., Luu, H. H., & He, T. (2016) · Journal of Biomedical Research · doi:10.7555/jbr.29.20150075 · Cited by 45 · see citing works

Identification and analysis of key genes in osteosarcoma using bioinformatics

Diao, C., Xi, Y., & Xiao, T. (2017) · Oncology Letters · doi:10.3892/ol.2017.7649 · Cited by 45 · see citing works

Identification of Key Genes Affecting Results of Hyperthermia in Osteosarcoma Based on Integrative ChIP-Seq/TargetScan Analysis

Shi, Y., Yang, F., Wei, S., & Xu, G. (2017) · Medical Science Monitor · doi:10.12659/msm.901191 · Cited by 44 · see citing works

Wnt Signaling in Ewing Sarcoma, Osteosarcoma, and Malignant Peripheral Nerve Sheath Tumors

Pridgeon, M. G., Grohar, P. J., Steensma, M. R., & Williams, B. O. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0377-9 · Cited by 44 · see citing works

Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling

Cao, B., Yang, W., Jin, Y., Zhang, M., He, T., Zhan, Q., Herman, J. G., Zhong, G., & Guo, M. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.06.015 · Cited by 43 · see citing works

Early methionine availability attenuates T cell exhaustion

Sharma, P., Guo, A., Poudel, S., Boada-Romero, E., Verbist, K., Palacios, G., Immadisetty, K., Chen, J., Haydar, D., Mishra, A., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02223-6 · Cited by 43 · see citing works

Osteoblast-Specific Wnt Secretion Is Required for Skeletal Homeostasis and Loading-Induced Bone Formation in Adult Mice

Lawson, L. Y., Brodt, M. D., Migotsky, N., Chermside‐Scabbo, C. J., Palaniappan, R., & Silva, M. J. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4445 · Cited by 42 · see citing works

Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth

Dong, Y., Cao, B., Zhang, M., Han, W., Herman, J. G., Fuks, F., Zhao, Y., & Guo, M. (2015) · Oncotarget · doi:10.18632/oncotarget.4244 · Cited by 41 · see citing works

Old Mice Have Less Transcriptional Activation But Similar Periosteal Cell Proliferation Compared to Young-Adult Mice in Response to in vivo Mechanical Loading

Chermside‐Scabbo, C. J., Harris, T. L., Brodt, M. D., Brænne, I., Zhang, B., Farber, C. R., & Silva, M. J. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4031 · Cited by 41 · see citing works

Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention

Klec, C., Gutschner, T., Panzitt, K., & Pichler, M. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1570499 · Cited by 40 · see citing works

The multiple function of long noncoding RNAs in osteosarcoma progression, drug resistance and prognosis

Xu, S., Gong, Y., Yin, Y., Xing, H., & Zhang, N. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110141 · Cited by 40 · see citing works

NUDT2 Disruption Elevates Diadenosine Tetraphosphate (Ap4A) and Down-Regulates Immune Response and Cancer Promotion Genes

Marriott, A. S., Vasieva, O., Fang, Y., Copeland, N. A., McLennan, A. G., & Jones, N. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154674 · Cited by 39 · see citing works

Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma

Hayashi, M., Baker, A. C., Goldstein, S. D., Albert, C. M., Jackson, K. W., McCarty, G., Kahlert, U. D., & Loeb, D. M. (2017) · Oncotarget · doi:10.18632/oncotarget.19432 · Cited by 37 · see citing works

miR-130b targets NKD2 and regulates the Wnt signaling to promote proliferation and inhibit apoptosis in osteosarcoma cells

Li, Z., Li, Y., Wang, N., Yang, L., Zhao, W., & Zeng, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.050 · Cited by 34 · see citing works

Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by up-regulating SOX18 in human gastric cancer

Jia, Y., Cao, B., Yang, Y., Linghu, E., Zhan, Q., Lu, Y., Yu, Y., Herman, J. G., & Guo, M. (2015) · Oncotarget · doi:10.18632/oncotarget.5272 · Cited by 33 · see citing works

Canine osteosarcoma in comparative oncology: Molecular mechanisms through to treatment discovery

Simpson, S., Rizvanov, A. A., Jeyapalan, J. N., de Brot, S., & Rutland, C. S. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.965391 · Cited by 34 · see citing works

Predictors of clinical responses to hypomethylating agents in acute myeloid leukemia or myelodysplastic syndromes

Wang, H., Li, Y., Lv, N., Li, Y., Wang, L., & Yu, L. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3464-9 · Cited by 32 · see citing works

Genetic Factors Conferring Metastasis In Osteosarcoma

Maximov, V. V., & Aqeilan, R. I. (2016) · Future Oncology · doi:10.2217/fon-2016-0014 · Cited by 30 · see citing works

MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophages in osteosarcoma

Nirala, B. K., Patel, T. D., Kurenbekova, L., Shuck, R. L., Dasgupta, A., Rainusso, N. C., Coarfa, C., & Yustein, J. T. (2023) · JCI Insight · doi:10.1172/jci.insight.164947 · Cited by 30 · see citing works

Direct conversion of osteosarcoma to adipocytes by targeting TNIK

Hirozane, T., Masuda, M., Sugano, T., Sekita, T., Goto, N., Aoyama, T., Sakagami, T., Uno, Y., Moriyama, H., Sawa, M., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.137245 · Cited by 24 · see citing works

Functional interplay between long non-coding RNAs and the Wnt signaling cascade in osteosarcoma

He, J., Ling, L., Liu, Z., Ren, X., Wan, L., Tu, C., & Li, Z. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02013-8 · Cited by 25 · see citing works

Molecular Characterisation of Canine Osteosarcoma in High Risk Breeds

Simpson, S., Dunning, M., de Brot, S., Alibhai, A. A., Bailey, C., Woodcock, C. L., Mestas, M., Akhtar, S., Jeyapalan, J. N., Lothion‐Roy, J. H., et al. (2020) · Cancers · doi:10.3390/cancers12092405 · Cited by 26 · see citing works

Multi‐genic pattern found in rare type of hypopituitarism: a whole‐exome sequencing study of Han Chinese with pituitary stalk interruption syndrome

Guo, Q., Wang, C., Wu, Z., Qin, Y., Han, B., Wang, A., Wang, B., Dou, J., Wu, X., & Mu, Y. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13272 · Cited by 24 · see citing works

Zinc finger antisense 1: A long noncoding RNA with complex roles in human cancers

Jiang, X., Yang, Z., & Li, Z. (2018) · Gene · doi:10.1016/j.gene.2018.11.075 · Cited by 24 · see citing works

miR-181c associates with tumor relapse of high grade osteosarcoma

Mori, F., Sacconi, A., Canu, V., Ganci, F., Novello, M., Anelli, V., Covello, R., Ferraresi, V., Muti, P. C., Biagini, R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3539 · Cited by 21 · see citing works

Coamplification of M yc/ P vt1 and homozygous deletion of N lrp1 locus are frequent genetics changes in mouse osteosarcoma

Rao, P. H., Zhao, S., Zhao, Y., Yu, A., Rainusso, N. C., Trucco, M. M., Allen‐Rhoades, W. A., Satterfield, L., Fuja, D. G., Borra, V. J., et al. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22291 · Cited by 21 · see citing works

FH535 Suppresses Osteosarcoma Growth In Vitro and Inhibits Wnt Signaling through Tankyrases

Gustafson, C. T., Mamo, T., Shogren, K. L., Maran, A., & Yaszemski, M. J. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00285 · Cited by 21 · see citing works

Epigenetic silencing of the Wnt antagonist APCDD1 by promoter DNA hyper-methylation contributes to osteosarcoma cell invasion and metastasis

Han, W., & Liu, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.07.049 · Cited by 21 · see citing works

Engineering oncolytic vaccinia virus to redirect macrophages to tumor cells

Cao, F., Nguyen, P., Hong, B., DeRenzo, C. C., Rainusso, N. C., Rodríguez-Cruz, T., Wu, M., Liu, H., Song, X., Suzuki, M., et al. (2020) · Advances in Cell and Gene Therapy · doi:10.1002/acg2.99 · Cited by 21 · see citing works

Inhibition of PDT-induced PGE2 surge for enhanced photo-immunotherapy

Liu, X., Huang, J., Zhou, H., Wang, S., Guo, X., Mao, J., Li, X., Lu, Y., Du, Y., Yang, F., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123116 · Cited by 20 · see citing works

Novel Thienopyrimidine Derivative, RP-010, Induces β-Catenin Fragmentation and Is Efficacious against Prostate Cancer Cells

Amawi, H. A., Hussein, N. A., Boddu, S. H. S., Karthikeyan, C., Williams, F. E., Ashby, C. R., Raman, D., Trivedi, P., & Tiwari, A. K. (2019) · Cancers · doi:10.3390/cancers11050711 · Cited by 19 · see citing works

Identification of key genes as predictive biomarkers for osteosarcoma metastasis using translational bioinformatics

Ding, F.-P., Tian, J., Wu, J., Han, D., & Zhao, D. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02308-w · Cited by 18 · see citing works

Knockdown of SALL4 Inhibits Proliferation, Migration, and Invasion in Osteosarcoma Cells

Zhang, D., Jiang, F., Wang, X., & Li, G. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14772402056137 · Cited by 17 · see citing works

Targeting Signaling Pathway by Curcumin in Osteosarcoma

Asemi, Z., Yousefi, B., Farnood, P. R., & Pazhooh, R. D. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220408104341 · Cited by 16 · see citing works

Expression pattern and clinical significance of β-catenin gene and protein in patients with primary malignant and benign bone tumors

Khademian, N., Mirzaei, A., Hosseini, A., Zare, L., Nazem, S., Babaheidarian, P., Sheikhi, A., Abdolvahabi, Z., Ibrahimi, M., Jamshidi, K., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-13685-1 · Cited by 16 · see citing works

Low expression of NKD2 is associated with enhanced cell proliferation and poor prognosis in human hepatocellular carcinoma

Wang, D., Zhang, S., Chen, Y., Hu, B., & Lu, C. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.09.016 · Cited by 15 · see citing works

Biological evaluation of mitochondria targeting small molecules as potent anticancer drugs

Luo, S., Dang, X., Wang, J., Chang, Y., Hu, Y., Lei, S., Zhang, Y., Lü, D., Jiang, F., & Fu, L. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105055 · Cited by 15 · see citing works

Celastrol increases osteosarcoma cell lysis by γδ T cells through up-regulation of death receptors

Li, Z., Junzhe, Z., Tang, J., & Wang, R. (2016) · Oncotarget · doi:10.18632/oncotarget.12756 · Cited by 15 · see citing works

Transglutaminase-2 promotes metastatic and stem-like phenotypes in osteosarcoma.

Fuja, D. G., Rainusso, N. C., Shuck, R. L., Kurenbekova, L., Donehower, L. A., & Yustein, J. T. (2018) · Europe PMC (PubMed Central) · Cited by 15 · see citing works

Metastasis-Initiating Osteosarcoma Subpopulations Establish Paracrine Interactions with Lung and Tumor Cells to Create a Metastatic Niche

Reinecke, J. B., Garcia, L. J., Saraf, A. J., Hinckley, J., Gross, A. C., Pommellet, H. L., Gutpell, K. M., Cam, M., Cannon, M. V., Gust, M. J., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-3360 · Cited by 13 · see citing works

Epigenetic dysregulation of NKD2 is a valuable predictor assessing treatment outcome in acute myeloid leukemia

Li, X., Zhou, J., Zhang, T., Yang, L., Wen, X., Ma, J., Yang, J. C., Zhang, Z., Lin, J., & Qian, J. (2017) · Journal of Cancer · doi:10.7150/jca.16914 · Cited by 13 · see citing works

miRNA‐34c Suppresses Osteosarcoma Progression In Vivo by Targeting Notch and E2F

Bae, Y., Zeng, H., Chen, Y., Ketkar, S., Munivez, E. M., Yu, Z., Gannon, F. H., & Lee, B. (2022) · JBMR Plus · doi:10.1002/jbm4.10623 · Cited by 12 · see citing works

Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis

Тодосенко, Н. М., Хлусов, И. А., Yurova, K. A., Геннадьевна, Х. О., & Litvinova, L. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108993 · Cited by 12 · see citing works

The role of lncRNA and miRNA on the effects of occurrence and development of osteosarcoma

Zhang, X., Gao, X., Xu, J., Zhang, Z., Lin, T., Zhang, X., & Kang, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113726 · Cited by 11 · see citing works

Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia

Zhou, J., Yao, D., Han, L., Xiao, G.-F., Guo, H. Y., Zhang, T., Li, X., Yuan, Q., Yang, L., Lin, J., et al. (2017) · Tumor Biology · doi:10.1177/1010428317699123 · Cited by 10 · see citing works

Overcoming PD-1 Inhibitor Resistance with a Monoclonal Antibody to Secreted Frizzled-Related Protein 2 in Metastatic Osteosarcoma

Nasarre, P., Garcia, D. I., Siegel, J. B., Bonilla, I. V., Mukherjee, R. D., Hilliard, E., Chakraborty, P., Nasarre, C., Yustein, J. T., Lang, M., et al. (2021) · Cancers · doi:10.3390/cancers13112696 · Cited by 10 · see citing works

Logistic regression analysis for the identification of the metastasis-associated signaling pathways of osteosarcoma

Liu, Y., Sun, W. Y., Ma, X., Hao, Y., Liu, G., Hu, X., Shang, H., Wu, P., Zhao, Z., & Liu, W. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3360 · Cited by 10 · see citing works

Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcoma

Ringwalt, E. M., Currier, M. A., Glaspell, A. M., Chen, C., Cannon, M. V., Cam, M., Gross, A. C., Gust, M. J., Wang, P.-Y., Boon, L., et al. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200886 · Cited by 9 · see citing works

Transcriptome of Lung Cancer Cells Resistant to the Cytotoxic Activity of Macrophages

Kovaleva, O. V., Алексеевна, П. П., Vasileva, M., Kopnin, P., Balkin, A. S., Plotnikov, A. O., Kushlinskii, N. E., & Gratchev, A. N. (2022) · Doklady Biochemistry and Biophysics · doi:10.1134/s160767292205009x · Cited by 9 · see citing works

Network model integrated with multi-omic data predicts MBNL1 signals that drive myofibroblast activation

Nelson, A. R., Bugg, D., Davis, J., & Saucerman, J. J. (2023) · iScience · doi:10.1016/j.isci.2023.106502 · Cited by 9 · see citing works

Blocking fatty acid synthase inhibits tumor progression of human osteosarcoma by regulating the human epidermal growth factor receptor 2/phosphoinositide 3-kinase/protein kinase B signaling pathway in xenograft models

Chen, X. Y., Ruan, H. B., Long, X. H., Peng, A. F., Zhou, L., Liu, J. M., Zhou, Y., & Liu, Z. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4284 · Cited by 9 · see citing works

Downregulation of NKD1 in human osteosarcoma and its clinical significance

Chen, X., Xu, P., Zhu, J., & Liu, F. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7968 · Cited by 9 · see citing works

Nkd2 promotes the differentiation of dental follicle stem/progenitor cells into osteoblasts

Chen, C., Zhan, J., Ling, J., Du, Y., & Hou, Y. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3822 · Cited by 9 · see citing works

Silencing of estrogen receptor β promotes the invasion and migration of osteosarcoma cells through activating Wnt signaling pathway

Zhang, Y., Yin, C., Xufeng, Z., Wu, Y., & Wang, L. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s219222 · Cited by 9 · see citing works

LINC00922: A Critical Oncogenic Long Non‐Coding RNA Involved in Cancer Progression, Chemotherapy Resistance, and microRNA Regulation

Si, J., Liang, C., Zhang, X., Xu, H., Su, X., Liu, L., Yuan, R., Ding, Y., & Duan, S. (2025) · Medicine Advances · doi:10.1002/med4.70018 · Cited by 8 · see citing works

Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide

Byrgazov, K., Anderson, C. N., Salzer, B., Bozsaky, E., Larsson, R. L., Gullbo, J., Lehner, M., Lehmann, F., Slipicevic, A., Kager, L., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920937891 · Cited by 8 · see citing works

Expression and prognostic significance of NKD2 in ovarian cancer

Wei, W., Zheng, L., Gao, Y., He, M., & Yang, F. (2020) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaa244 · Cited by 7 · see citing works

In Vitro and In Vivo Characterization of a Preclinical Irradiation-Adapted Model for Ewing Sarcoma

Shapiro, M. C., Tang, T. T., Dasgupta, A., Kurenbekova, L., Shuck, R. L., Gaber, M. W., & Yustein, J. T. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.01.095 · Cited by 7 · see citing works

MicroRNA‑1236‑3p inhibits human osteosarcoma growth

Li, J., Chen, J., Hu, Z., & Xu, W. (2020) · Oncology Letters · doi:10.3892/ol.2020.12229 · Cited by 7 · see citing works

LRRC15-CAR T Cells for the Treatment of Osteosarcoma

O'Reilly, C., Tuladhar, S., Nguyen, P. T., Sheppard, H., Koo, S. C., Chockley, P. J., Houke, H., Santiago, T., Tian, L., Jeschke, J., et al. (2026) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-2335 · Cited by 6 · see citing works

Gliosarcomas lack BRAFV600E mutation, but a subset exhibit β‐catenin nuclear localization

Schwetye, K. E., Joseph, N. M., Al‐Kateb, H., Rich, K. M., Schmidt, R. E., Perry, A., Gutmann, D. H., & Dahiya, S. M. (2016) · Neuropathology · doi:10.1111/neup.12293 · Cited by 6 · see citing works

Machine learning-based prediction of diagnostic markers for Graves’ orbitopathy

Cai, Y., Su, H., Si, Y., & Ni, N. (2023) · Endocrine · doi:10.1007/s12020-023-03349-z · Cited by 6 · see citing works

Copy number variation in archival melanoma biopsies versus benign melanocytic lesions

Mahas, A., Potluri, K., Kent, M. N., Naik, S., & Markey, M. P. (2016) · Cancer Biomarkers · doi:10.3233/cbm-160600 · Cited by 6 · see citing works

Preclinical models for the study of pediatric solid tumors: focus on bone sarcomas

Petrescu, D. I., Yustein, J. T., & Dasgupta, A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1388484 · Cited by 5 · see citing works

NKD2 as a Mediator of IFIX Antioncogene‐Induced Wnt Signalling and Epithelial–Mesenchymal Transition in Human OSCC

Wang, S., Li, F., Fan, H., & Bai, J. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70342 · Cited by 5 · see citing works

Dynein: A Multifaceted Therapeutic Target and Its Dysregulation in Aberrant Cell Proliferation

Garg, J., & Alisaraie, L. (2025) · Cytoskeleton · doi:10.1002/cm.22041 · Cited by 5 · see citing works

Endogenous retrovirus envelope as a tumor-associated immunotherapeutic target in murine osteosarcoma

Wedekind, M. F., Miller, K. E., Chen, C., Wang, P.-Y., Hutzen, B. J., Currier, M. A., Nartker, B. A., Roberts, R. D., Boon, L., Conner, J., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102759 · Cited by 5 · see citing works

NKD2 mediates stimulation-dependent ORAI1 trafficking to augment Ca2+ entry in T cells

Wu, B., Woo, J. S., Vila, P., Jew, M., Leung, J., Sun, Z., Srikanth, S., & Gwack, Y. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109603 · Cited by 5 · see citing works

Downregulation of NKD1 in human osteosarcoma and its clinical significance

Chen, X., Xu, P., Zhu, J., & Liu, F. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7968 · Cited by 9 · see citing works

NKX2-2 Suppresses Osteosarcoma Metastasis and Proliferation by Downregulating Multiple Target Genes

Chen, H.-M., Liu, W., Zhong, L., Liao, D., Zhang, R., Kang, T., & Wu, Y. (2018) · Journal of Cancer · doi:10.7150/jca.26382 · Cited by 26 · see citing works

Abstract 3867: Novel mouse models to investigate the molecular pathogenesis of metastatic osteosarcoma.

Zhao, S., Kurenbekova, L., Donehower, L. A., & Yustein, J. T. (2013) · Cancer Research · doi:10.1158/1538-7445.am2013-3867

Abstract A85: Novel mouse models to investigate the molecular pathogenesis of metastatic osteosarcoma

Zhao, S., Kurenbekova, L., Donehower, L. A., & Yustein, J. T. (2013) · Cancer Research · doi:10.1158/1538-7445.tim2013-a85

Necdin Inhibits the Proliferation of Osteosarcoma Cells and Lung Metastasis by Wnt/β-catenin signaling pathwayPreprint

Wu, Z., Chen, S., Shen, Z., Wu, T., Li, J., Feng, Y., Zhang, L., Huang, L., Guo, L., Qiao, X., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1936030/v1